Leadership Archive - Page 77 of 79 - Medical Affairs Professional Society

Krishna Bahadursingh

December 9, 2019/in /by Medical Affairs

Dr Krishna Bahadursingh joined Syneos Health in Tokyo, Japan, as Regional Vice President, Medical APAC/Japan on July 1st. His main responsibility would be to build out the Medical Affairs function to capitalize on the available opportunities and for Syneos in Japan/Asia Pacific.
He joined the pharma industry from clinical practice, working for both Japanese headquartered and MNC companies and spent more than two decades in multi- disciplinary, thought- leadership roles central to ensuring patient safety and regulatory compliance as well as spearheading evolution in the medical affairs function from a support organization to a value-added one fully dedicated to delivering favorable reported outcomes for both patients and their families.
Krishna has resided primarily in Tokyo, Japan for the past 20 years but has also lived or worked in a number of countries in Asia. In addition to his medical qualifications and experience he is a Fellow of the Royal College of Surgeons (FRCS), Fellow of the of the Faculty of Pharmaceutical Medicine (FFPM), holds an Executive MBA and is also an attorney-at-law (LLB). He is a member of the Association of Medical Doctors in Asia AMDA).

Cezary Statuch

December 7, 2019/in APAC Leadership Committee/by Medical Affairs

Dr Cezary Statuch joined Biogen in January 2015 and is currently the Vice President of Medical for the region of International Markets. His career in the pharmaceutical industry spans almost 30 years. During his professional life Cezary has held positions in clinical research operations, global drug development and medical affairs. Prior to joining Biogen, Cezary led the China Research and Development team for Bristol-Myers Squibb. He was involved in managing activities in China for almost 15 years, 7 of which he spent living in Shanghai. Cezary is actively engaged in the training and education of physicians in the healthcare industry across many emerging and established markets. He is a founding member of the China Medical Affairs Network. He is also a member of the Executive Committee of the Medical Affairs Professional Society. Cezary is passionate about promoting access to medicines across Emerging Markets to address unmet medical needs and help patients to prevail against serious medical conditions.

KAREN WOOLLEY

December 7, 2019/in /by Medical Affairs

Karen is the Global Lead for Patient Partnerships at Envision Pharma Group and oversees staff in Envision’s Tokyo and Sydney offices. She has 30 years of experience in the healthcare sector, gained in academia, hospital, industry (Pfizer, Johnson & Johnson), and agency (ProScribe Medical Communications, Envision Pharma Group) environments, in North America and the Asia Pacific region. Karen has a strong focus on strategic initiatives in the medical affairs sector and has led international teams to conduct and publish research on publications ethics and on patient engagement and involvement in industry-sponsored research. Karen is a Professor at two universities and has been a government-appointed director overseeing 6 hospitals, serving on the Patient Safety and Quality Committee, and managing a $2B budget. She was the inaugural chair of the Asia Pacific Advisory Committee for the International Society of Medical Publication Professionals, is an Honorary Fellow of the American Medical Writers Association, a Life Member of the Australasian Society of Clinical and Regulatory Scientists (ARCS), an Editorial Board Member for the Research Integrity and Peer Review journal, and is the only author from the Asia Pacific region on the international Good Publication Practice for Communicating Company-Sponsored Research (GPP3) guidelines and the Joint Position Statement on the Role of Professional Medical Writers. Karen is regularly invited to present her research and share her insights at major international and regional conferences.

ZHIHUI (ZIG) LANG

December 7, 2019/in /by Medical Affairs

Dr. Lang is the Senior Vice President and Head of Medical Affairs and Pharmacovigilance at Bayer Healthcare China including Hong Kong. In this role, Dr. Lang directs the Medical Affairs, Medical Science Liaisons, Medical Communications, Scientific Operations, Medical Compliance, Patient Support and Disease Management Programs, Health Economics and Outcome Research and Pharmacovigilance.
Prior to coming to Bayer China, Dr. Lang worked in Bayer’s Global Medical Affairs Oncology in the United States. Dr. Lang has over 18 years of pharmaceutical industry experiences ranging from early and late stage clinical development to medical affairs. Dr. Lang held positions with increasing responsibilities at Endo Pharmaceuticals, Johnson and Johnson, Wyeth and Novo Nordisk. Dr. Lang is a board-certified oncologist and hematologist. He received his medical education at the Fourth Military Medical University in Xi’an and PhD in Biochemistry at Rush University in Chicago.

Paul Theron

Paul qualified as a physician, in South Africa, more than 30 years ago. Since then he has worked in private practice as a general practitioner and in various roles, from medical manager to medical director, in the pharmaceutical industry, covering Boehringer Ingelheim, AstraZeneca, Takeda and Merck. Other current roles include Executive member of MAPS JPAC and Past President of APPA. Currently he is responsible for strategy and operations in APAC and has a special interest in the future of digital health and how it will be implemented in the future

Julie L. White

March 4, 2025/in EE MC Boston 25/by Jalene Kaiser

Donnie Wooten Jr.

April 22, 2022/in Field Medical/by Medical Affairs

ALAN MCDOUGALL

December 7, 2019/in /by Medical Affairs

Dr Alan McDougall is currently Vice President and Head of Medical Affairs, Asia Oceania. Alan qualified in medicine in 1984 from the University of Glasgow in Scotland. He trained as a family doctor and worked in and around Glasgow for 14 years. Alan joined Novo Nordisk in 1998, becoming their UK Medical Director in 2001 and after leadership positions with both BioMarin Europe and AstraZeneca, he joined Astellas as their UK Medical Director in 2009 before moving to a regional European role in 2014 and subsequently Vice President and Head of Asia-Pacific Medical Affairs in 2016.

Ajay Tiku

December 7, 2019/in APAC Leadership Committee/by Medical Affairs

Dr Ajay Tiku completed his MBChB training in Zambia and M.Med Internal Medicine in South Africa. An executive management-training program from Vanderbilt University, USA, and an Executive Leadership Program from IMD University, Switzerland has added to his exceptional leadership style. Following eight years of clinical practice in Africa, Dr Tiku went on to gain vast experience in the field of medical affairs, and scientific research & development. He has worked for just about two decades, with Global research based pharmaceutical organizations. Dr Tiku has published in the area of Diabetes and has been a guest speaker at healthcare related meetings in various countries. He has gained work experience within the USA, Africa and Asia at various roles and senior positions of responsibility. He is currently living and working in a leadership role within the Pharmaceutical industry, based in Singapore, along with his wife and two children.

Troels Wolther

March 9, 2021/in /by Medical Affairs

Troels is an Australian and Danish citizen, with a Medical Degree and PhD from Aarhus University, Denmark, with a past special academic interest in Diabetes, Endocrinology, and Hepatology, but with 21 years of broad industry experience across therapeutic areas.

Troels has a proven track record in developing and managing high-performing teams, external relationship creation and management, and identifying and developing the synergies between patient and business outcomes, all to the overall benefit of both patients, physicians and healthcare systems. He possesses superior both technical medical/scientific, organizational and people management skills and has worked in both Local, Regional and Global roles and functions within industry. Similarly, he has worked across a broad spectrum of country archetypes, including working across the Asia Pacific, China, India & Japan geographies, Europe and the US, propelling organizations into excellence by means of a crisp focus on driving patient outcomes, scientific excellence, digitalization and a strong emphasis on people & culture.

He currently is the Executive Medical Director for Amgen Australia.

Follow Us